Heart procedure upgrade: could extra ablation stop AFib return?
NCT ID NCT07191626
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two heart procedures for people with paroxysmal atrial fibrillation (AFib), a condition where the heart beats irregularly. One group gets standard ablation to isolate the pulmonary veins, while the other also gets ablation of the superior vena cava using pulsed field energy. Researchers will track 650 participants for 12 months to see if the extra step reduces AFib recurrence without causing more complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pulsed field ablation procedure
What this could lead to
If successful, this could offer a more effective ablation strategy for paroxysmal atrial fibrillation, reducing the chance of irregular heartbeats returning.
What could go wrong
This is an early-stage trial with 12-month follow-up, so long-term benefits are unknown. Adding extra ablation may increase risks like nerve injury or heart rhythm problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROXYSMAL ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
The First Affiliated Hospital of Naval Medical University (Shanghai Changhai Hospital). No. 168, Changhai Road, Yangpu District, Shanghai, China.
Shanghai, Shanghai Municipality, 200040, China
Contact Phone: •••-•••-••••